Belgium· BE-AMP-SAM585271-00
Magnence 243 mg
A magnesium aspartate product containing magnesium aspartate dihydrate, registered in Belgium by Kora Corporation t/a Kora Healthcare. The same ATC class is registered in 7 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Magnesium aspartate is registered in 7 of 19 countries.
Countries holding a registration under ATC A12CC05 (magnesium aspartate), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 3 of them publish a price we can compare per daily dose
Magnesium aspartate · ATC A12CC05
7 / 19 countries
- Belgiumprice
- Germany
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Magnesium Aspartate Dihydrate
- Manufacturer
- Kora Corporation t/a Kora Healthcare
- Country
- Belgium (BE)
- ATC code
- A12CC05
- ATC class
- Magnesium aspartate
- Defined daily dose
- 10 mmol, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb4748430
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
13 interactions on record for magnesium aspartate.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Magnesium aspartate · interactions on record
13 records
13 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Magnesium aspartate in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAsparMag 243mg (magnesium 10mmol) oral powder sachetsEssential-Healthcare Ltd
- NetherlandsMagnence 243 mg poeder voor drankKora Corporation Ltd t/a Kora Healthcare
- GermanyEmgeVerla-Pharm Arzneimittel Gmbh & Co. Kg
- SwitzerlandMg 5-Granoral 12mmol arôme pêche-abricot, granulé buvableOM Pharma Suisse SA
- PolandAsmagPrzedsiębiorstwo Farmaceutyczne Farmapol Sp. z o.o.
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Austria · Emgecard, Magnesiocard
- Bulgaria · Магнерич
- Cyprus · Trofocard
- Germany · Emge, Magnaspart
- United Kingdom (Northern Ireland) · Anosumag
- Greece · Magnesil, Overmag
- Poland · Asmag, Asmag Forte
- Portugal · Magnesiocard, Magnesiocard Sem Açúcar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6d493aa0-bcaf-4c92-a0c7-477cd67b2499 GET /v1/drugs/6d493aa0-bcaf-4c92-a0c7-477cd67b2499?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for oral solution",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Magnence 243 mg",
"name_fr": "Magnence 243 mg",
"name_nl": "Magnence 243 mg",
"amp_code": "SAM585271-00",
"strengths": [
"3246.0000",
"243.0000",
"18.0000",
"2706.0000"
],
"pack_count": 2,
"substances": [
"Magnesium Aspartate Dihydrate",
"Magnesium",
"Saccharin Sodium",
"Sucrose"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Magnesium Aspartate",
"authorisation_numbers": [
"BE585271"
]
}See everything about magnesium aspartate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.